vs
Side-by-side financial comparison of NATIONAL RESEARCH CORP (NRC) and Orchid Island Capital, Inc. (ORC). Click either name above to swap in a different company.
Orchid Island Capital, Inc. is the larger business by last-quarter revenue ($38.5M vs $35.2M, roughly 1.1× NATIONAL RESEARCH CORP). Orchid Island Capital, Inc. runs the higher net margin — 268.7% vs 5.1%, a 263.6% gap on every dollar of revenue. On growth, Orchid Island Capital, Inc. posted the faster year-over-year revenue change (372.6% vs -4.6%). Over the past eight quarters, Orchid Island Capital, Inc.'s revenue compounded faster (301.6% CAGR vs -0.2%).
National Research Corporation, doing business as NRC Health, is an American healthcare company which provides healthcare products and subscription-based solutions in United States and Canada. It was founded in 1981, and is based in Lincoln, Nebraska.
Orchid Island Capital, Inc. is a U.S.-based specialty finance company operating as a real estate investment trust. It primarily invests in residential mortgage-backed securities, including agency and non-agency products, targeting consistent risk-adjusted returns for its investors across U.S. fixed income markets.
NRC vs ORC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $35.2M | $38.5M |
| Net Profit | $1.8M | $103.4M |
| Gross Margin | — | — |
| Operating Margin | 13.3% | — |
| Net Margin | 5.1% | 268.7% |
| Revenue YoY | -4.6% | 372.6% |
| Net Profit YoY | -72.6% | 1764.9% |
| EPS (diluted) | $49.58 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $35.2M | $38.5M | ||
| Q3 25 | $34.6M | $26.9M | ||
| Q2 25 | $34.0M | $23.2M | ||
| Q1 25 | $33.6M | $19.7M | ||
| Q4 24 | $36.9M | — | ||
| Q3 24 | $35.8M | $340.0K | ||
| Q2 24 | $35.0M | $-697.0K | ||
| Q1 24 | $35.3M | $-2.5M |
| Q4 25 | $1.8M | $103.4M | ||
| Q3 25 | $4.1M | $72.1M | ||
| Q2 25 | $-106.0K | $-33.6M | ||
| Q1 25 | $5.8M | $17.1M | ||
| Q4 24 | $6.6M | — | ||
| Q3 24 | $5.7M | $17.3M | ||
| Q2 24 | $6.2M | $-5.0M | ||
| Q1 24 | $6.4M | $19.8M |
| Q4 25 | 13.3% | — | ||
| Q3 25 | 22.4% | — | ||
| Q2 25 | 4.7% | — | ||
| Q1 25 | 25.6% | — | ||
| Q4 24 | 26.0% | — | ||
| Q3 24 | 22.3% | — | ||
| Q2 24 | 25.3% | — | ||
| Q1 24 | 24.8% | — |
| Q4 25 | 5.1% | 268.7% | ||
| Q3 25 | 11.9% | 267.8% | ||
| Q2 25 | -0.3% | -145.0% | ||
| Q1 25 | 17.2% | 86.9% | ||
| Q4 24 | 17.8% | — | ||
| Q3 24 | 15.9% | 5094.1% | ||
| Q2 24 | 17.6% | 714.3% | ||
| Q1 24 | 18.0% | -794.2% |
| Q4 25 | $49.58 | — | ||
| Q3 25 | $0.18 | — | ||
| Q2 25 | $-0.01 | — | ||
| Q1 25 | $0.25 | — | ||
| Q4 24 | $0.27 | — | ||
| Q3 24 | $0.24 | — | ||
| Q2 24 | $0.26 | — | ||
| Q1 24 | $0.27 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.1M | $665.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $14.0M | $1.4B |
| Total Assets | $134.9M | $11.7B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.1M | $665.9M | ||
| Q3 25 | $2.2M | $583.9M | ||
| Q2 25 | $5.3M | $440.8M | ||
| Q1 25 | $2.5M | $396.4M | ||
| Q4 24 | $4.2M | — | ||
| Q3 24 | $3.5M | $322.1M | ||
| Q2 24 | $485.0K | $241.0M | ||
| Q1 24 | $1.7M | $190.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $48.7M | — | ||
| Q2 24 | $33.3M | — | ||
| Q1 24 | $35.2M | — |
| Q4 25 | $14.0M | $1.4B | ||
| Q3 25 | $14.3M | $1.1B | ||
| Q2 25 | $21.3M | $912.0M | ||
| Q1 25 | $29.7M | $855.9M | ||
| Q4 24 | $31.3M | — | ||
| Q3 24 | $34.6M | $656.0M | ||
| Q2 24 | $40.2M | $555.9M | ||
| Q1 24 | $36.9M | $481.6M |
| Q4 25 | $134.9M | $11.7B | ||
| Q3 25 | $135.7M | $9.1B | ||
| Q2 25 | $141.4M | $7.6B | ||
| Q1 25 | $135.2M | $7.3B | ||
| Q4 24 | $132.5M | — | ||
| Q3 24 | $131.8M | $5.9B | ||
| Q2 24 | $119.1M | $4.9B | ||
| Q1 24 | $120.9M | $4.2B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.41× | — | ||
| Q2 24 | 0.83× | — | ||
| Q1 24 | 0.95× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $7.2M | $120.4M |
| Free Cash FlowOCF − Capex | $6.1M | — |
| FCF MarginFCF / Revenue | 17.2% | — |
| Capex IntensityCapex / Revenue | 3.2% | — |
| Cash ConversionOCF / Net Profit | 3.99× | 1.16× |
| TTM Free Cash FlowTrailing 4 quarters | $15.7M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $7.2M | $120.4M | ||
| Q3 25 | $13.8M | $28.0M | ||
| Q2 25 | $-1.1M | $18.4M | ||
| Q1 25 | $6.6M | $25.8M | ||
| Q4 24 | $6.4M | — | ||
| Q3 24 | $9.4M | $-14.8M | ||
| Q2 24 | $6.8M | $19.3M | ||
| Q1 24 | $12.0M | $45.0M |
| Q4 25 | $6.1M | — | ||
| Q3 25 | $10.2M | — | ||
| Q2 25 | $-4.1M | — | ||
| Q1 25 | $3.7M | — | ||
| Q4 24 | $1.9M | — | ||
| Q3 24 | $7.8M | — | ||
| Q2 24 | $1.5M | — | ||
| Q1 24 | $7.9M | — |
| Q4 25 | 17.2% | — | ||
| Q3 25 | 29.4% | — | ||
| Q2 25 | -12.2% | — | ||
| Q1 25 | 10.9% | — | ||
| Q4 24 | 5.2% | — | ||
| Q3 24 | 21.8% | — | ||
| Q2 24 | 4.3% | — | ||
| Q1 24 | 22.4% | — |
| Q4 25 | 3.2% | — | ||
| Q3 25 | 10.4% | — | ||
| Q2 25 | 8.8% | — | ||
| Q1 25 | 8.9% | — | ||
| Q4 24 | 12.0% | — | ||
| Q3 24 | 4.5% | — | ||
| Q2 24 | 15.0% | — | ||
| Q1 24 | 11.7% | — |
| Q4 25 | 3.99× | 1.16× | ||
| Q3 25 | 3.34× | 0.39× | ||
| Q2 25 | — | — | ||
| Q1 25 | 1.15× | 1.51× | ||
| Q4 24 | 0.97× | — | ||
| Q3 24 | 1.66× | -0.86× | ||
| Q2 24 | 1.10× | — | ||
| Q1 24 | 1.89× | 2.28× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
